Tempus AI Total Assets 2023-2025 | TEM

Tempus AI total assets from 2023 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Tempus AI total assets for the quarter ending March 31, 2025 were $1.543B, a 228.84% increase year-over-year.
  • Tempus AI total assets for 2024 were $0.926B, a 64.19% increase from 2023.
  • Tempus AI total assets for 2023 were $0.564B, a 10.66% decline from 2022.
  • Tempus AI total assets for 2022 were $0.631B, a 0% decline from .
Tempus AI Annual Total Assets
(Millions of US $)
2024 $926
2023 $564
2022 $631
Tempus AI Quarterly Total Assets
(Millions of US $)
2025-03-31 $1,543
2024-12-31 $926
2024-09-30 $972
2024-06-30 $865
2024-03-31 $469
2023-12-31 $564
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $631
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.403B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.731B 53.50
Hims & Hers Health (HIMS) United States $11.944B 124.09
IRhythm Technologies (IRTC) United States $4.673B 0.00
Inspire Medical Systems (INSP) United States $4.222B 65.97
Privia Health (PRVA) United States $2.843B 194.33
Enovis (ENOV) United States $1.910B 10.65
Clover Health Investments (CLOV) United States $1.634B 0.00
Schrodinger (SDGR) United States $1.578B 0.00
Phreesia (PHR) United States $1.484B 0.00
Omnicell (OMCL) United States $1.387B 24.47
Azenta (AZTA) United States $1.269B 58.98
10x Genomics (TXG) United States $1.058B 0.00
Butterfly Network (BFLY) United States $0.626B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.494B 147.50
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.391B 0.00
TruBridge (TBRG) United States $0.361B 801.00
Outset Medical (OM) United States $0.333B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.32
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00